Accelerating BPC-PaCo through Visually Lossless Techniques

Fast image codecs are a current need in applications that deal with large amounts of images. Graphics Processing Units (GPUs) are suitable processors to speed up most kinds of algorithms, especially when they allow fine-grain parallelism. Bitplane Coding with Parallel Coefficient processing (BPC-PaCo) is a recently proposed algorithm for the core stage of wavelet-based image codecs tailored for the highly parallel architectures of GPUs. This algorithm provides complexity scalability to allow faster execution at the expense of coding efficiency. Its main drawback is that the speedup and loss in image quality is controlled only roughly, resulting in visible distortion at low and medium rates. This paper addresses this issue by integrating techniques of visually lossless coding into BPC-PaCo. The resulting method minimizes the visual distortion introduced in the compressed file, obtaining higher-quality images to a human observer. Experimental results also indicate 12% speedups with respect to BPC-PaCo.     

基于机器视觉的轮胎表面缺陷检测系统的研究与应用

在传统的轮胎表面缺陷依靠人工检测,存在劳动强度高、受人的主观影响大以及效率低下的问题。针对这一现象,研究了一种基于机器视觉的轮胎表面缺陷3D检测系统。该系统依靠机器视觉系统获取检测轮胎的表面图像,然后创建3D模型、判定缺陷类型,最终实现实时自动预警,为轮胎生产商提供一种自动化检测方案。系统集成了先进的技术、软件和工具,配套的信息管控系统可以对轮胎型号和生产数据进行采集、存储、分析,以便在生产过程中实现更高效、更可靠的质量控制,具有较高的实际应用推广价值。     

印刷电路板缺陷检测的实际应用

电路板在我们的日常生活中非常常见,这就使得印刷电路板的缺陷检测显得尤为重要。AOI作为新兴的检测PCB板缺陷的系统,在生产实际中正在被大家熟知并且应用。相较于传统的检测方式,AOI系统比较灵活,无论是在检测时间还是系统运算上,或者是对相关技术人员的要求相较于传统方式都比较有优势,本文就AOI系统在实际中的应用展开讨论,分析并且介绍了在实际应用中的具体细则。     

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

Lung cancer is one of the most common malignant neoplasms. As a result of the disease’s progression, patients may develop metastases to the central nervous system. The prognosis in this location is unfavorable; untreated metastatic lesions may lead to death within one to two months. Existing therapies—neurosurgery and radiation therapy—do not improve the prognosis for every patient. The discovery of Epidermal Growth Factor Receptor (EGFR)—activating mutations and Anaplastic Lymphoma Kinase (ALK) rearrangements in patients with non-small cell lung adenocarcinoma has allowed for the introduction of small-molecule tyrosine kinase inhibitors to the treatment of advanced-stage patients. The Epidermal Growth Factor Receptor (EGFR) is a transmembrane protein with tyrosine kinase-dependent activity. EGFR is present in membranes of all epithelial cells. In physiological conditions, it plays an important role in the process of cell growth and proliferation. Binding the ligand to the EGFR causes its dimerization and the activation of the intracellular signaling cascade. Signal transduction involves the activation of MAPK, AKT, and JNK, resulting in DNA synthesis and cell proliferation. In cancer cells, binding the ligand to the EGFR also leads to its dimerization and transduction of the signal to the cell interior. It has been demonstrated that activating mutations in the gene for EGFR-exon19 (deletion), L858R point mutation in exon 21, and mutation in exon 20 results in cancer cell proliferation. Continuous stimulation of the receptor inhibits apoptosis, stimulates invasion, intensifies angiogenesis, and facilitates the formation of distant metastases. As a consequence, the cancer progresses. These activating gene mutations for the EGFR are present in 10–20% of lung adenocarcinomas. Approximately 3–7% of patients with lung adenocarcinoma have the echinoderm microtubule-associated protein-like 4 (EML4)/ALK fusion gene. The fusion of the two genes EML4 and ALK results in a fusion gene that activates the intracellular signaling pathway, stimulates the proliferation of tumor cells, and inhibits apoptosis. A new group of drugs—small-molecule tyrosine kinase inhibitors—has been developed; the first generation includes gefitinib and erlotinib and the ALK inhibitor crizotinib. These drugs reversibly block the EGFR by stopping the signal transmission to the cell. The second-generation tyrosine kinase inhibitor (TKI) afatinib or ALK inhibitor alectinib block the receptor irreversibly. Clinical trials with TKI in patients with non-small cell lung adenocarcinoma with central nervous system (CNS) metastases have shown prolonged, progression-free survival, a high percentage of objective responses, and improved quality of life. Resistance to treatment with this group of drugs emerging during TKI therapy is the basis for the detection of resistance mutations. The T790M mutation, present in exon 20 of the EGFR gene, is detected in patients treated with first- and second-generation TKI and is overcome by Osimertinib, a third-generation TKI. The I117N resistance mutation in patients with the ALK mutation treated with alectinib is overcome by ceritinib. In this way, sequential therapy ensures the continuity of treatment. In patients with CNS metastases, attempts are made to simultaneously administer radiation therapy and tyrosine kinase inhibitors. Patients with lung adenocarcinoma with CNS metastases, without activating EGFR mutation and without ALK rearrangement, benefit from immunotherapy. This therapeutic option blocks the PD-1 receptor on the surface of T or B lymphocytes or PD-L1 located on cancer cells with an applicable antibody. Based on clinical trials, pembrolizumab and all antibodies are included in the treatment of non-small cell lung carcinoma with CNS metastases.     

A novel fusion paradigm for multi-channel image denoising

Multi-channel and single-channel image denoising are on two important development fronts. Integrating multi-channel and single-channel image denoisers for further improvement is a valuable research direction. A natural assumption is that using more useful information is helpful to the output results. In this paper, a novel multi-channel and single-channel fusion paradigm (MSF) is proposed. The proposed MSF works by fusing the estimates of a multi-channel image denoiser and a single-channel image denoiser. The performance of recent multi-channel image denoising methods involved in the proposed MSF can be further improved at low additional time-consuming cost. Specifically, the validity principle of the proposed MSF is that the fused single-channel image denoiser can produce auxiliary estimate for the involved multi-channel image denoiser in a designed underdetermined transform domain. Based on the underdetermined transformation, we create a corresponding orthogonal transformation for fusion and better restore the multi-channel images. The quantitative and visual comparison results demonstrate that the proposed MSF can be effectively applied to several state-of-the-art multi-channel image denoising methods.     

Economic Indicators

Currency exchanges rates – updated monthly. Economic indicators of industrial production. Countries included: France, Germany, Italy, the United Kingdom, the United States, Canada, Japan (Total G-7), Eurozone and Total EU-28 (Total OECD). Updated monthly. Economic indicators of car registration in the United States, Canada, France, Germany, Italy, Poland, Spain, Turkey, the United Kingdom, Japan, Republic of Korea and Other OECD (Total OECD-30). Updated monthly. Monthly averages of crude steel production in thousand metric tons for the United States, Canada, Brazil, Mexico, Austria, Belgium, Czech Republic, France, Germany, Italy, Netherlands, Poland, Spain, Sweden, Turkey, the United Kingdom, Russia, Ukraine, South Africa, Iran, China, India, Japan, Republic of Korea, Taiwan and Australia.     

Incidence and costs of bicycle-related traumatic brain injuries in the Netherlands

The main cause of death and serious disability in bicycle accidents is traumatic brain injury (TBI). The aim of this population-based study was to assess the incidence and costs of bicycle-related TBI across various age groups, and in comparison to all bicycle-related injuries, to identify main risk groups for the development of preventive strategies.Data from the National Injury Surveillance System and National Medical Registration were used for all patients with bicycle-related injuries and TBI who visited a Dutch emergency department (ED) between 1998 and 2012. Demographics and national, weighted estimates of injury mechanism, injury severity and costs were analysed per age group. Direct healthcare costs and indirect costs were determined using the incidence-based Dutch Burden of Injury Model.Between 1998 and 2012, the incidence of ED treatments due to bicycle-related TBI strongly increased with 54%, to 43 per 100,000 persons in 2012. However, the incidence of all bicycle-related injuries remained stable, from 444 in 1998 to 456/100,000 in 2012. Incidence of hospital admission increased in both TBI (92%) and all injuries from cycling (71%). Highest increase in incidence of both ED treatments and hospital admissions was seen in adults aged 55+. The injury rate of TBI per kilometre travelled increased (44%) except in children, but decreased (−4%) for all injuries, showing a strong decrease in children (−36%) but an increase in men aged 25+, and women aged 15+. Total costs of bicycle-related TBI were €74.5 million annually. Although bicycle-related TBI accounted for 9% of the incidence of all ED treatments due to cycling, it accounted for 18% of the total costs due to all bicycle-related injuries (€410.7 million). Children and adolescents (aged 0–24) had highest incidence of ED treatments due to bicycle-related injuries. Men in the working population (aged 15–64) had highest indirect costs following injuries from cycling, including TBI. Older cyclists (aged 55+) were identified as main risk group for TBI, as they had highest ED attendance, injury rate, injury severity, admission to hospital or intensive care unit, and costs.Incidence of ED treatments due to cycling are high and often involve TBI, imposing a high burden on individuals and society. Older cyclists aged 55+ were identified as main risk group for TBI to be targeted in preventive strategies, due to their high risk for (serious) injuries and ever-increasing share of ED visits and hospital admissions.     

Economic Indicators

Currency exchanges rates – updated monthly. Economic indicators of industrial production. Countries included: France, Germany, Italy, the United Kingdom, the United States, Canada, Japan (Total G-7), Eurozone and Total EU-28 (Total OECD). Updated monthly. Economic indicators of car registration in the United States, Canada, France, Germany, Italy, Poland, Spain, Turkey, the United Kingdom, Japan, Republic of Korea and Other OECD (Total OECD-30). Updated monthly. Monthly averages of crude steel production in thousand metric tons for the United States, Canada, Brazil, Mexico, Austria, Belgium, Czech Republic, France, Germany, Italy, Netherlands, Poland, Spain, Sweden, Turkey, the United Kingdom, Russia, Ukraine, South Africa, Iran, China, India, Japan, Republic of Korea, Taiwan and Australia.     

Inverse identification of constitutive parameters from heat source fields: A local approach applied to hyperelasticity

In this paper, a new inverse identification method of constitutive parameters is developed from full kinematic and thermal field measurements. It consists in reconstructing the heat source field from two different approaches by using the heat diffusion equation. The first one requires the temperature field measurement and the value of the thermophysical parameters. The second one is based on the kinematic field measurement and the choice of a thermo-hyperelastic model that contains the parameters to be identified. The identification is carried out at the local scale, ie, at any point of the heat source field, without using the boundary conditions. In the present work, the method is applied to the challenging case of hyperelasticity from a heterogeneous test. Due to large deformations undergone by the rubber specimen tested, a motion compensation technique is developed to plot the kinematic and the thermal fields at the same points before reconstructing the heterogeneous heat source field. In the present case, the constitutive parameter of the Neo-Hookean model has been identified, and its distribution has been characterized with respect to the strain state at the surface of a cross-shaped specimen.